Inhibition of e. Coli and s. aureus with selenium nanoparticles synthesized by pulsed laser ablation in deionized water

International Journal of Nanomedicine

Volumn 11, Issue , 2016, Pages 3731-3736

  Guisbiers, G ^a   Wang, Q ^b   Khachatryan, E ^a   Mimun, L C ^a   Mendoza Cruz, R ^a   Larese Casanova, P ^b   Webster, T J ^b,c   Nash, K L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b Northeastern University   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Antibiotics resistant; Bacteria; Cytotoxicity; Nosocomial disease

Indexed keywords

SELENIUM NANOPARTICLE; ANTIINFECTIVE AGENT; NANOPARTICLE; SELENIUM; WATER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; GROWTH INHIBITION; IN VITRO STUDY; MIC50; NONHUMAN; PARTICLE SIZE; STAPHYLOCOCCUS AUREUS; ZETA POTENTIAL; CHEMISTRY; DRUG EFFECTS; LASER; MICROBIAL SENSITIVITY TEST; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; LASERS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; SELENIUM; STAPHYLOCOCCUS AUREUS; WATER;

EID: 84983261343     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S106289     Document Type: Article

References (22)

1. Inweregbu K, Dave, J, Pittard A. Nosocomial infections. Cont Educ Anaesth Crit Care Pain. 2005;5(1):14-17.
2. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemoth. 1992;29(Suppl A):19-24.
3. Pollack A. Rising threat of infections unfazed by antibiotics. New York Times; 2010.
4. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629-641.
5. Kaufmann SH. The contribution of immunology to the rational design of novel antibacterial vaccines. Nat Rev Microbiol. 2007;5(7):491-504.
6. Zhu X, Radovic-Moreno AF, Wu J, Langer R, Shi J. Nanomedicine in the management of microbial infection-overview and perspectives. Nano Today. 2014; 9(4):478-498.
7. Rayman MP. Selenium and human health. Lancet. 2012;379(9822): 1256-1268.
8. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005;64(4):527-542.
9. Ramamurthy Ch, Sampath KS, Arunkumar P, et al. Green synthesis and characterization of selenium nanoparticles and its augmented cytotoxicity with doxorubicin on cancer cells. Bioprocess Biosyst Eng. 2013;36(8):1131-1139.
10. Tran PA, Webster TJ. Antimicrobial selenium nanoparticle coatings on polymeric medical devices. Nanotechnology. 2013;24(15): 155101.
11. Zeng H, Du X-W, Singh SC, et al. Nanomaterials via laser ablation/irradiation in liquid: a review. Adv Funct Mater. 2012;22:1333-1353.
12. Singh SC, Mishra SK, Srivastava, RK, Gopal R. Optical properties of selenium quantum dots produced with laser irradiation of water suspended Se nanoparticles. J Phys Chem C. 2010;114:17374-17384.
13. Kuzmin PG, Shafeev GA, Voronov VV, et al. Bioavailable nanoparticles obtained in laser ablation of a selenium target in water. Quant Electron. 2012;42(11):1042-1044.
14. Van Overschelde O, Guisbiers G, Snyders R. Green synthesis of selenium nanoparticles by excimer pulsed laser ablation in water. APL Mater. 2013;1:042114.
15. Guisbiers G, Wang Q, Khachatryan E, et al. Anti-bacterial selenium nanoparticles produced by UV/VIS/NIR pulsed nanosecond laser ablation in liquids. Laser Phys Lett. 2015;12(1):016003.
16. Van Overschelde O, Guisbiers G. Photo-fragmentation of selenium powder by excimer laser ablation in liquids. Opt Laser Technol. 2015;73:156-161.
17. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163-175.
18. Kieliszek M, Błażejak S, Gientka I, Bzducha-Wróbel A. Accumulation and metabolism of selenium by yeast cells. Appl Microbiol Biotechnol. 2015;99(13):5373-5382.
19. Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2010;2(5):a000414.
20. Nakayama H, Kurokawa K, Lee BL. Lipoproteins in bacteria: structures and biosynthetic pathways. FEBS J. 2012;279(23):4247-4268.
21. Tran PA, O’Brien-Simpson N, Reynolds EC, Pantarat N, Biswas DP, O’Connor AJ. Low cytotoxic trace element selenium nanoparticles and their differential antimicrobial properties against S. aureus and E. coli. Nanotechnology. 2016;27(4):045101.
22. Greulich C, Braun D, Peetsch A, et al. The toxic effect of silver ions and silver nanoparticles towards bacteria and human cells occurs in the same concentration range. RSC Adv. 2012;2(17):6981-6987.